Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

PURPOSE: We sought to determine whether the combination of ixabepilone plus capecitabine improved overall survival (OS) compared with capecitabine alone in patients with metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes. PATIENTS AND METHODS: A total of 1,221 patients...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sparano, Joseph A., Vrdoljak, Eduard, Rixe, Oliver, Xu, Binghe, Manikhas, Alexey, Medina, Carlos, Ventilari Da Costa, Susanne Crocamo, Ro, Jungsil, Rubio, Gonzalo, Rondinon, Monica, Perez Manga, Gumersindo, Peck, Ronald, Poulart, Valerie, Conte, Pierfranco
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2010
Konular:
Original Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903325/
https://ncbi.nlm.nih.gov/pubmed/20530276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.24.4244
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller